CSE: $HBOR OAKLAND, CA and TORONTO, Aug. 23, 2019

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
172
CSE: $HBOR OAKLAND, CA and TORONTO, Aug. 23, 2019 /PRNewswire/ - Harborside Inc. ("Harborside" or the "Company" (CSE: HBOR), is pleased to announce that, subject to regulatory approval, it has retained Generation Advisors Inc. ("Generation" and Mackie Research Capital Corporation ("Mackie" to provide trading, market stabilization and liquidity services for the Company in accordance with regulatory guidelines. Generation and Mackie will trade the subordinate voting shares of Harborside (the "Shares" on the Canadian Securities Exchange (the "CSE" for the purposes of maintaining a reasonable market and improving the liquidity of the Shares.

Under the issuer trading services agreement between Generation and the Company (the "Generation Agreement", the Company has agreed to pay Generation a fee of C$7,500, plus applicable taxes, per month, payable quarterly in advance. The initial term of the Generation Agreement will last for 180 days, and such term will be automatically renewed for a subsequent three month period unless terminated earlier by 30 days' prior written notice by the Company to Generation. Generation will also have the right to terminate the Generation Agreement at any time upon prior written notice to the Company.

Under the letter agreement between Mackie and the Company (the "Mackie Agreement", the Company has agreed to pay Mackie an all-inclusive flat fee of C$5,000 per month, payable in advance. The engagement will be ongoing on a month-to-month basis and may be terminated by either party with written notice of 30 days. The Mackie Agreement is principally for the purposes of maintaining market stability and liquidity for the Shares and is not a formal market making agreement.

There are no performance factors contained in the Generation Agreement nor the Mackie Agreement. Neither Generation nor Mackie will receive any shares or options from the Company as compensation for services it will render.

About Harborside:

Harborside Inc. is one of the oldest, largest and most respected cannabis retailers in the world, operating two of the major dispensaries in the San Francisco Bay Area, two dispensaries in Oregon, and a cultivation facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. Co-founded by Steve DeAngelo and dress wedding in 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States. Harborside is currently a publicly listed company on the CSE, trading under the ticker symbol "HBOR". Additional information regarding Harborside is available under Harborside's SEDAR profile at www.sedar.com, including in Harborside's Listing Statement dated May 30, 2019.
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 20

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 13

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 15

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 14

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 14

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 14

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 14

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

FDA's NMN Ruling: Naturecan Seizes Opportunities for Growth

Updated Category News Views 158

FDA's NMN Ruling and Its Significance Naturecan, a prominent global wellness brand, is thrilled by the recent ruling from the U.S. Food and Drug Administration (FDA) regarding ?-Nicotinamide Mononucleotide (NMN). This ruling confirms that NMN is lawful for use in dietary supplements in the United States, paving the way for significant advancements within the global...

Continue Reading
Casepoint Secures Major SEC Contract for Innovative Data Solutions

Updated Category News Views 184

Casepoint Secures Important Contract Extension with the SEC Casepoint, a leading company in data discovery technology, has successfully extended its contract with the U.S. Securities and Exchange Commission (SEC). This five-year agreement highlights Casepoint's dedication to providing secure, cloud-based solutions designed for regulatory enforcement and compliance in a...

Continue Reading
Intel Corp's Future with Apple: Chip Manufacturing Wins

Updated Category News Views 359

Intel Corp's Significant Stock Surge Intel Corp (NASDAQ: INTC) saw its stock rise by 7%, thanks to a report signaling the company's exciting potential to produce chips for Apple Inc's upcoming Mac models. Industry analyst Ming-Chi Kuo from TF International Securities provided an optimistic outlook, suggesting Intel is gaining traction in its efforts to expand operations....

Continue Reading
Significant Phase II Breakthrough for Akeso's Ivonescimab in NSCLC

Updated Category News Views 195

Akeso's Promising Results with Ivonescimab for Lung Cancer Akeso (9926.HK) has recently shared exciting findings from the Phase II study of ivonescimab, a groundbreaking PD-1/VEGF bispecific antibody designed to treat resectable non-small cell lung cancer (NSCLC). This study was highlighted during a key oral session at the 25th World Conference on Lung Cancer (WCLC),...

Continue Reading
Insider Trades at Sherwin-Williams: A Closer Look at Rea's Moves

Updated Category News Views 204

Recent Insider Trading Activity at Sherwin-Williams Todd Rea, who holds the position of President at Sherwin-Williams (NYSE: SHW), has recently become the center of attention due to his stock option activities. The latest SEC filing reveals that he made a notable decision by exercising options for zero shares of the company’s stock. What This Means for Investors In the...

Continue Reading